650
Participants
Start Date
March 17, 2023
Primary Completion Date
December 3, 2025
Study Completion Date
September 6, 2028
DOR/ISL
FDC tablet of 100 mg doravirine (DOR)/0.25 mg islatravir (ISL) taken once daily
Hôpitaux Universitaires de Genève (HUG)-Infectious Disease Department ( Site 2804), Geneva
Holdsworth House Medical Practice ( Site 1100), Darlinghurst
St Vincent's Hospital-IBAC ( Site 1103), Sydney
Perinatal HIV Research Unit (PHRU)-Adult Treatment and Research ( Site 2605), Johannesburg
Helen Joseph Hospital-Clinical HIV Research Unit ( Site 2609), Johannesburg
Ezintsha-Clinical Research Site ( Site 2607), Johannesburg
Inselspital Bern-Inselspital Infektiologie ( Site 2803), Bern
Prahran Market Clinic ( Site 1102), Melbourne
Holdsworth House Medical Practice - Brisbane ( Site 1101), Brisbane
Wentworth Hospital ( Site 2604), Durban
University Hospital Basel-Infectiology ( Site 2802), Basel
Ospedale Regionale di Lugano, Sede Civico-Servizio Malattie Infettive ( Site 2805), Lugano
Family Clinical Research Unit (Fam-Cru)-Adult Infectious Diseases ( Site 2608), Cape Town
Be Part Yoluntu Centre ( Site 2601), Paarl
Desmond Tutu Health Foundation ( Site 2602), Cape Town
Christchurch Hospital-Infectious Diseases ( Site 2200), Christchurch
UniversitätsSpital Zürich ( Site 2800), Zurich
Cantonal Hospital St.Gallen ( Site 2801), Sankt Gallen
Josha Research ( Site 2603), Bloemfontein
Icahn School of Medicine at Mount Sinai-Clinical and Translational Research Center ( Site 3134), New York
Penn Medicine: University of Pennsylvania Health System-Perelman Center for Advanced Medicine ( Site, Philadelphia
Georgetown University Medical Center ( Site 3130), Washington D.C.
Infectious Disease Specialists of Atlanta ( Site 3128), Decatur
Augusta University-Infectious Diseases ( Site 3135), Augusta
Mercer university, Department of internal medicine-Clinical Research ( Site 3129), Macon
Chatham County Health Department - Chatham CARE Center-Infectious Disease ( Site 3105), Savannah
Orlando Immunology Center ( Site 3106), Orlando
Bliss Healthcare Services ( Site 3115), Orlando
Floridian Clinical Research, LLC ( Site 3133), Miami Lakes
AHF The Kinder Medical Group ( Site 3108), Miami
Therafirst Medical Center ( Site 3110), Fort Lauderdale
Triple O Research Institute, P.A ( Site 3116), West Palm Beach
CAN Community Health - Sarasota ( Site 3118), Sarasota
Midway Immunology and Research Center ( Site 3117), Ft. Pierce
University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 3104), Birmingham
KC CARE Health Center ( Site 3103), Kansas City
Sourasky Medical Center ( Site 1904), Tel Aviv
North Texas Infectious Diseases Consultants, P.A ( Site 3100), Dallas
DCOL Center for Clinical Research ( Site 3119), Longview
Texas Centers for Infectious Disease Associates ( Site 3111), Fort Worth
The Crofoot Research Center ( Site 3101), Houston
St Hope Foundation ( Site 3121), Bellaire
Kaohsiung Veterans General Hospital ( Site 2901), Kaohsiung City
Pueblo Family Physicians ( Site 3102), Phoenix
Kaiser Permanente ( Site 3124), Los Angeles
Ruane Clinical Research Group, Inc ( Site 3126), Los Angeles
Mills Clinical Research ( Site 3114), Los Angeles
Pacific Oaks Medical Group ( Site 3123), Beverly Hills
University of California Davis Health-Internal Medicine: Infectious Diseases ( Site 3137), Sacramento
Private Practice - Dr. Peter Shalit ( Site 3120), Seattle
Multicare Institute for Research and Innovation ( Site 3127), Spokane
Moscow Infectious Diseases Clinical Hospital Number 2 ( Site 2506), Moscow
Hospital Universitario San Ignacio-Infectious ( Site 1501), Bogotá
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 1502), Bogotá
Scientific Advisory Clinical Diagnostic Center Central Resea-Federal AIDS Center ( Site 2502), Moscow
Saint-Petersburg Center for Prophylactic of AIDS and Infecti-Saint-Petersburg Center for Prophylact, Saint Petersburg
Republican Clinical Infectious Hospital ( Site 2500), Saint Petersburg
Republican Clinical Hospital for Infectious Diseases A.F. Agafonova ( Site 2503), Kazan'
Kemerovo Regional Center for the Prevention and Control of AIDS and Infectious Diseases ( Site 2505), Kemerovo
Krasnoyarsk Regional Center for the Prevention and Control of AIDS ( Site 2504), Krasnoyarsk
Fundación Valle del Lili ( Site 1500), Santiago de Cali
Rambam Health Care Campus-Institute of Allergy, Clinical Immunology, ( Site 1901), Haifa
Clinica Universidad Catolica del Maule ( Site 1405), Talca
Hospital hernan henriquez aravena de temuco-Unidad de Investigación Clínica ( Site 1403), Temuco
Sheba Medical Center-HIV unit ( Site 1903), Ramat Gan
Biomedica Research Group-Infectology ( Site 1401), Santiago
Pontificia Universidad Catolica de Chile ( Site 1407), Santiago
Universidad de Chile - Hospital Clínico Universidad de Chile-Inmunologia Alergia y VIH ( Site 1400), Santiago
Cardio Sur ( Site 1409), Santiago
Hadassah Medical Center-Infecious Disease ( Site 1902), Jerusalem
ID Care ( Site 3131), Hillsborough
Instituto Oulton ( Site 1004), Córdoba
Instituto CAICI SRL ( Site 1003), Rosario
Helios Salud ( Site 1002), Buenos Aires
Fundación Huésped ( Site 1001), Buenos Aires
Fundación IDEAA ( Site 1005), Buenos Aires
Hamilton Health Sciences- Urgent Care Centre ( Site 1304), Hamilton
Maple Leaf Research ( Site 1301), Toronto
Toronto General Hospital ( Site 1300), Toronto
Clinique de médecine Urbaine du Quartier Latin ( Site 1305), Montreal
Clinique Medicale lActuel ( Site 1303), Montreal
McGill University Health Centre ( Site 1306), Montreal
National Hospital Organization Nagoya Medical Center ( Site 2103), Nagoya
Tokyo Metropolitan Komagome Hospital ( Site 2105), Bunkyo
Tokyo Medical University Hospital ( Site 2104), Shinjuku-ku
Center Hospital of the National Center for Global Health and Medicine ( Site 2101), Shinjyuku-ku
National Hospital Organization - Osaka National Hospital - Institute For Clinical Research ( Site 21, Osaka
Clinical Research Puerto Rico ( Site 2400), San Juan
HOPE Clinical Research ( Site 2401), San Juan
Private Practice Dr. Marleen de Jager ( Site 2600), Pretoria
University Hospitals Sussex NHS Foundation Trust ( Site 3004), East Sussex
Southmead Hospital ( Site 3003), Bristol
Royal Free Hospital ( Site 3002), London
King's College Hospital ( Site 3001), London
North Manchester General Hospital ( Site 3005), Crumpsall
Merck Sharp & Dohme LLC
INDUSTRY